Skip to content

VACCINOGEN INC

company.status.inactive

CIK 1453001fmd_0CXQX4NVW25YMSVT2XE8G1J2TXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2015, 13 periods

Income Statement · Annual · Millions · USD
Line itemFY2012FY2013FY2014
Total revenues000
Research and development899
Total operating expenses111915
Operating income(11)(19)(15)
Interest expense021
Income before taxes–(25)(8)
Income tax expense000
Net income from continuing operations–(25)(9)
Net income(29)(25)(9)
Net income to common shareholders–(25)(9)